FGFR

The world’s first achondroplasia drug

The world’s first achondroplasia drug

BioMarin is a global biotechnology company dedicated to developing and commercializing innovative therapies for patients with severe and life-threatening rare and ultra-rare genetic diseases. Its product portfolio includes seven commercial […]